Gilead Sciences
GILD
GILD
1,674 hedge funds and large institutions have $78B invested in Gilead Sciences in 2023 Q3 according to their latest regulatory filings, with 130 funds opening new positions, 681 increasing their positions, 630 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.29% less ownership
Funds ownership: 83.66% → 83.37% (-0.29%)
3% less capital invested
Capital invested by funds: $80.5B → $78B (-$2.48B)
1% less funds holding
Funds holding: 1,693 → 1,674 (-19)
Holders
1,674
Holding in Top 10
31
Calls
$919M
Puts
$816M
Top Buyers
| 1 | +$218M | |
| 2 | +$121M | |
| 3 | +$120M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$99.7M |
| 5 |
JP Morgan Chase
New York
|
+$68.3M |
Top Sellers
| 1 | -$212M | |
| 2 | -$155M | |
| 3 | -$126M | |
| 4 |
Renaissance Technologies
New York
|
-$100M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$96.1M |